IGC Pharma, Inc.
IGC
$0.29
$0.000.32%
AMEX
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -83.61% | -100.50% | -6.06% | 32.76% | 58.51% |
| Total Depreciation and Amortization | -60.28% | -62.34% | -17.93% | -12.96% | -6.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.88% | 68.97% | -183.76% | 6.47% | 16.89% |
| Change in Net Operating Assets | 240.32% | 131.19% | -133.51% | -708.06% | -117.68% |
| Cash from Operations | 4.05% | -67.53% | -109.84% | 19.69% | -38.78% |
| Capital Expenditure | 37.50% | 94.44% | 0.00% | 78.95% | -20.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -243.75% | -- | 1,100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.42% | -14.19% | -519.23% | -22.58% | 52.26% |
| Cash from Investing | -143.79% | -19.72% | -475.38% | 542.75% | 56.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00% | 0.00% | -- |
| Issuance of Common Stock | 21.95% | -89.19% | 291.32% | -66.03% | 20.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.29% | -11.80% | 291.69% | -66.06% | 20.69% |
| Foreign Exchange rate Adjustments | -108.00% | -600.00% | 145.45% | 1,150.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.06% | -966.15% | 334.17% | -92.17% | 63.89% |